This study, based on data from the MANIF 2000 cohort study, investigates the relationship between the lending of injecting equipment, drug use, and experience with HIV care. The sample comprised 224 HIVÁHCV co-infected patients who reported having injected drugs in the previous six months and their 538 visits to clinical services. Longitudinal data were collected for medical status, and self-reported risk behaviors. A logistic regression GEE model was used to identify correlates of distributive sharing. After multiple adjustment, patients who reported trust in physicians were significantly less likely to report lending injection equipment while cocaine users were at increased risk. Promoting dialog between physicians and injecting drug users (IDUs) may play an important role in HIVÁHCV positive prevention.
Background
Even in countries that have adopted needle exchange programs (NEP) and expanded access to opioid substitution treatment (OST), the prevalence of HCV in injecting drug users (IDUs) remains extremely high (60Á70%) and even higher in those HIVinfected through drug use (Jauffret-Roustide et al., 2009 ). Among IDUs, HCV, like HIV, is mainly transmitted through needle sharing. However, HCV is more easily transmitted than HIV because its prevalence is greater, it is more resistant to desiccation (Centers for Disease Control and Prevention, 1998) and it is also linked to the sharing of drug paraphernalia (water, filter, spoon) (Hagan et al., 2001; McCoy, Metsch, Chitwood, Shapshak, & Comerford, 1998) . HCV infection can consequently occur after substantially less injection and fewer sharing episodes (Hahn et al., 2002; Miller et al., 2002) . All around the world, the current harm reduction (HR) policy seems to have been less effective in controlling HCV than HIV and consequently HR packages for controlling HCV are under evaluation. Targeting HIVÁHCV co-infected patients' risk behaviors is important, as interventions on this population may have a major role in controlling the spread of both HIV and HCV. Risks involved in injection practices greatly contribute to the spread of blood-borne transmitted diseases among IDUs (Alter, 2006) .
A range of interventions has been implemented to reduce the spread of blood-borne diseases among IDUs.
Even though HR interventions have been found to have an impact upon HIV prevalence and incidence among IDUs (Cazein et al., 2008; Des Jarlais et al., 2005; Van Den Berg, Smit, Van Brussel, Coutinho, & Prins, 2007) , some HIV-positive IDUs continue to engage in high-risk behaviors. There is an urgent need to develop and strengthen effective interventions for HIV-positive IDUs who are still engaged in high-risk behaviors.
The French HR policy has provided expanded and free access to OST (70% coverage), NEP (Emmanuelli & Desenclos, 2005) but HCV prevalence among IDUs is still high (Jauffret-Roustide et al., 2006) .
While several studies document incidence rates of HCV and the pattern of risk factors, little is known about HIVÁHCV risk practices in co-infected IDUs. Also, few studies take account of the serological status of IDUs involved in high-risk behaviors, and fewer studies have focused on distributive sharing among HIV/HCV co-infected IDUs (Metsch et al., The present study used data from the MANIF 2000 cohort of HIVÁHCV co-infected patients to identify whether experience with HIV care and access to ART, social demographic characteristics and specific use of drugs could influence the practice of distributive sharing among active IDUs. The study also investigated the role of the physician, and specifically of the trust in physician among HIVÁ HCV co-infected IDUs in relation to high-risk behaviors.
Method

Sample and setting
The sample comprised 224 HIVÁHCV co-infected patients who reported having injected drugs at least once in the six months prior to interview. Only visits where patients reported having injected were included in the data analysis (538 visits).
The sample was drawn from the MANIF 2000 cohort which enrolled 467 patients who were HIVinfected through injection drug use between July 1995 and May 1998. Patients were enrolled in hospitalbased outpatient HIV clinics and followed-up until 2007. Inclusion criteria for enrolment in the cohort included only patients with a CD4' cell count !300/ml in the last visit prior to enrolment and with clinical stages A or B. This cohort was designed to focus on social and behavioral aspects of HIVpositive IDUs and particularly on their access and adherence to ART.
All individuals who agreed to be interviewed signed an informed consent form, approved with the study protocol by the French committee responsible for the evaluation of work involving human subjects.
Procedure
Data collection (every six months) was based on medical records, a face-to-face interview and a selfadministered questionnaire. Clinical data, including CD4 cell count, HIV viral load and HIV clinical stage were derived from clinical records. The face-to-face interview was administered by trained nurses who gathered psychosocial information (social support and patient-physician relationship) as well as information about patients' personal experience with HIV infection and care. The questionnaire collected sociodemographic data, year of first drug injection, incarceration, several items about substance use and at-risk behaviors. All the data collected referred to the 6 months prior to the given visit.
Injecting drug use at any given visit thereafter was defined as the injection of heroin or morphine, psychotropic drugs, cocaine, buprenorphine, or any other drugs in the six months before that visit.
Depressive symptoms were detected using the French version of the Center for Epidemiological Studies Depression Scale (CES-D) (Fuhrer & Rouillon, 1989) . Although CES-D cannot be considered as a clinical tool for diagnosing depression, patients were considered to present depressive symptoms if their CES-D score was greater than 17 (for men) or greater than 23 (for women) (Radloff, 1977) .
A measure of the trust between physicians and their patient was calculated using a single item using a five-point Likert scale to score patient agreement with different suggested levels of trust in their physician. In the data analysis, the variable was dichotomized to contrast individuals reporting very high and high agreement vs. those reporting moderate, low, or very low agreement.
In order to minimize the risk of under-reporting, the definition of the outcome variable of ''distributive sharing at a given visit'' was based on several questions:
(1) Having lent syringe/needle or other paraphernalia at least once in the six previous months before the visit. 
Statistical methods
To determine factors associated with distributive sharing, only visits of those individuals reporting active injection during follow-up were included. A logistic regression GEE model was used to assess the independent effect of patientÁphysician relationship and individual characteristics on distributive sharing. Variables were considered eligible for entering the final models if in their p value was B0.25 in the univariate analysis. The final model was built using a backward procedure based on the log likelihood ratio test with pB0.05.
All the analyses were performed using Stata version 10.1.
Results
Among the 224 co-infected patients who also reported having injecting drugs at least once during the whole follow-up (four years on average, 993.5 person-years), 166 reported injection cessation for at AIDS Care 233 least one year during follow-up. The 243 individuals who were excluded because they never reported injection over the whole observation period, had longer duration of follow-up (six years on average, 1638.5 person-years).
The 224 Among the 224 patients accounting for 538 visits where injection six months prior the visit was reported, 157 (71%) reported having shared injecting equipment in 282 visits (54%); distributive sharing was reported by 57 patients (25%) in 82 visits (15%) and borrowing injection equipment was reported by 119 patients (53%) at 173 visits (32%).
The distribution of the main characteristics and behaviors observed at the selected visits and the associations between such characteristics and distributive sharing are presented in Table 1 .
When focusing on substance use behaviors, individuals reporting injection at these visits also reported, respectively, heroin or cocaine use in 70% and 50% of the selected visits while benzodiazepine in 49% of the visits. Experience of withdrawal symptoms was reported in 34% of visits. After adjustment for sociodemographic factors (age and employment), individuals reporting cocaine use were at increased risk of distributive sharing. Conversely, individuals reporting trust in physicians were significantly less likely to report lending injection equipment (Table 1) . However the adjustment for IMR (i.e., for inequity in ART access) did not affect the relationship between trust in physicians and distributive sharing.
It is interesting to note that trust in physicians was also associated with high adherence (p 00.001) and better virological outcomes (undetectable viral load p00.05), but not with ''systematic condom use in the 6 months prior to the visit with one's stable or occasional partner'' (p00.47).
Discussion
This study conducted in HIVÁHCV co-infected IDUs shows that the continued high level of sharing of injecting equipment remains a public health concern because of continuing concerns about the transmission of blood borne diseases, especially HIV and HCV.
The proportion of IDUs who reported distributive sharing is lower than that of IDUs who reported borrowing equipment. From a public health perspective and a co-infected prevention viewpoint, it is important to differentiate between borrowing and lending among HIV-infected patients. This result suggests that HIVÁHCV co-infected IDUs are to take more personal risks in terms of potential exposure to HCV re-infection or super-infections (Currie et al., 2008; van de Laar & Likatavicius, 2009 ) than they are to expose others to HCV risk by lending their injecting equipment. This behavior emphasizes the strategies used by IDUs to protect their community from HIV transmission by ''informed altruism'' (Des Jarlais et al., 2005) and the responsibility of IDUs (Rhodes et al., 2007) toward others. Interestingly, during the cohort follow-up, more than half of the IDUs studied had stopped injecting drugs (Bouhnik et al., 2004) .
In our study, younger age, unemployment, and recent cocaine use were risk factors associated with distributive sharing at least once in the previous 6 months. In most international literature, cocaine use is an important indicator of risky injecting (Compton, Lamb, & Fletcher, 1995; Santibanez et al., 2005) as it requires more frequent injections than other drugs, such as heroin (Patrick et al., 2001) , and particularly exposes IDUs to the risk of HIV and hepatitis transmission (Guadagnino et al., 1995) . Increasingly frequent cocaine injection can also lead to other infectious risks, like abscesses or other bacterial infections (Guadagnino et al., 1995; Hope, Kimber, Vickerman, Hickman, & Ncube, 2008; Hope, Marongiu, Parry, & Ncube, 2010) . HIVÁHCV co-infected IDUs are weakened and more susceptible to exposure to infectious complications due to sharing (Mertz, Viktorin, Wolbers, Fluckiger, & Battegay, 2009 ). This result also emphasizes the urgent need to associate HR measures with the development of new pharmacological treatment for stimulant dependence.
Age is also an important factor. Previous studies have shown that younger IDUs are more likely to engage in high-risk behaviors (Deren, Kang, Colon, Andia, & Robles, 2004) . Young people may tend to take more risks due to lack of information and shorter history and experience of drug injection. It is possible that there the ''generation gap'' factor also plays a role. Older IDUs lived during a time when AIDS decimated their circle of relationships and AIDS Care 235 generated within them the feeling that they are ''survivors'' (Nord, 1997) . There is a certain sense of guilt for staying alive and they pay particular attention to protecting themselves and others by minimizing risk-taking. Trust in one's physician was also found to be associated with a reduced likelihood of distributive sharing.
Since the onset of the AIDS epidemic, published studies have shown the difficult interaction between patients and physicians, particularly when the patient is an IDU (Hindler et al., 1996) and/or HIV-positive.
Although a delay in access to ART was observed for IDUs when ART first became available to HIVinfected persons (Carrieri et al., 1999) , today in France, access to ART for IDUs has considerably increased, largely due to the rapid scale-up of OST mainly through primary care, which improves patients' behavioral stabilization and rehabilitation (Spire, Lucas, & Carrieri, 2007) . Even if recent studies have shown that HIV-positive IDUs often report having suffered discrimination from health professionals and have poorer adherence to ART (Peretti-Watel, Spire, Lert, & Obadia, 2005) , the implementation of OST as a HR tool in primary care is likely to have fostered the dialog between doctors and patients regarding injection and at-risk practices. This has probably contributed to improve the overall quality of the relationship between HIV-infected IDUs and their physicians.
International literature has also shown that engaging in HIV care has a positive impact on the decrease of injecting drug use among HIVÁHCV co-infected IDUs (Bouhnik et al., 2004; Smit et al., 2006) .
It is possible that access to HIV or HCV care, through a more regular and trustful relationship with their HIV physicians can be considered by some patients as a unique opportunity to switch from a ''drug user'' status to that of an individual followedup for his/her HIV. This new identity makes some IDUs pay particular attention to their general health and also provides them the opportunity to reduce or renounce injection practices, or to inject only in safe contexts, thus minimizing the risk of transmission of blood borne diseases (Bouhnik et al., 2004) .
It is important to note that HIVÁHCV co-infected IDUs in France can be followed-up by multiple care providers (primary care physicians, HIV physicians, psychiatrists, hepatologists). However, the quality of the relationship may be different depending on the specialty of the physician, probably due to fear of judgment or stigma. For instance, it has been shown that HIVÁHCV co-infected patients tend to underreport alcohol use to their hepatologist (Roux et al., 2011) . HIV and primary care physicians in France were the first who provided care and prevention counseling for IDUs and were therefore less judgmental. It is not surprising that HIV physicians may have a better relationship with their patients, and that such patients are more sensitive to their counseling and adopt harm reduction practices.
At any rate, this result demonstrates the importance of strengthening the dialog and the therapeutic alliance between physicians (HIV or primary care physician) and their IDU patients. Specific training and collaborations with specialists in addiction is sometimes required (Ireland & McLeod, 1995) . Such collaborations may modify the perception that physicians may have regarding their IDU patients, often perceived as ''liars and manipulators'' (George & Martin, 1992; McGillion, Wanigaratne, Feinmann, Godden, & Byrne, 2000) .
This result has also important implications in terms of clinical management but also policy repercussions in terms of HR in the IDU community. In a meta-analysis (Martin, Garske, & Davis, 2000) , a consistent, positive, and moderately sized relationship between therapeutic alliance and treatment outcomes was found, and a review of recent studies (Meier, Donmall, Barrowclough, McElduff, & Heller, 2005; Meier, Donmall, McElduff, Barrowclough, & Heller, 2006) suggested that the trust in one's physician plays an important role in predicting drug treatment outcomes.
In interpreting these findings, certain limitations should be acknowledged. Firstly, in studies concerning self-reported at-risk practices, it is important to consider possible social desirability bias. For an HIVpositive person, distributive sharing is a very sensitive subject because there is a tendency to stigmatize lending behaviors. Though the validity and reliability of self-reports about drug use and risk practices have been established in studies using similar methods for data collection and processing (Darke, 1998; Latkin & Vlahov, 1998) , the risk of under-reporting for social desirability bias exists. This risk could result in a unidirectional misclassification of individuals lending their injecting equipment and therefore in a possible underestimation of the associations found. The study was also conducted with a very specific population, i.e., HIVÁHCV co-infected IDUs receiving hospital-based outpatient clinical care for their HIV disease. Because access to care in France is free, we assume that the study group may be representative of the wider HIV-infected population of IDUs.
Conclusions
Our study emphasized that high-risk behaviors are not only related to characteristics of patients but imply a strong relation with the social environment of IDUs (Rhodes, 2009) . Promoting the dialog between doctors and their opioid dependent/HIV/HCV patients can improve HIV and HCV prevention among IDUs.
